Medindia

X

MAP Pharmaceuticals Presents Analyses Showing LEVADEX Effective when Administered at Various Times in Migraine Cycle and in Patients with Concomitant Asthma

Wednesday, June 23, 2010 General News J E 4
Advertisement
-- FREEDOM-301 Analyses to be Presented at the AHS Annual Meeting --

CONTACTS:

Lisa Borland

MAP Pharmaceuticals, Inc.

(650) 386-3122

lborland@mappharma.com

Nicole Foderaro

WCG

(415) 946-1058

nfoderaro@wcgworld.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
EUCODIS Bioscience Launches LacBuster(TM), a High-...
S
SOKO Fitness & Spa Group Opens Two New Harbin Faci...